Pharmacological modulation of AGEs: a unique role for redox-active metal ions.
Weiss
M F
MF
Department of Internal Medicine, University Hospitals of Cleveland, Ohio 44106, USA.
Saxena
A K
AK
Monnier
V M
VM
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002614:Chelating Agents / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000737:chemistry / Q000378:metabolism*; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D008670:Metals / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010530:Peritoneal Dialysis; D014511:Uremia / Q000378:metabolism / Q000628:therapy
D000975:Antioxidants; D002614:Chelating Agents; D017127:Glycation End Products, Advanced; D006146:Guanidines; D008670:Metals; C048496:N(6)-carboxymethyllysine; D008239:Lysine; C004479:pimagedine